◆発表論文(英文)
Chinen T, Saeki E, Mori T, Sohara E, Uchida S, Akimoto T.
J Rural Med. 2019 Nov;14(2):258-262. doi: 10.2185/jrm.3014. Epub 2019 Nov 20.
Masuda T, Ohara K, Nagayama I, Matsuoka R, Murakami T, Nakagawa S, Oka K, Asakura M, Igarashi Y, Fukaya Y, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Nagata D.
Int Urol Nephrol. 2019 Sep;51(9):1623-1629.
3. Effcts of the sodium-glucose cotransporter2 inhibitor dapagliflozin on fluis distribution: A comparison study with furosemide and tolvaptan.
Ohara K, Masuda T, Murakami T, Imai T, Yoshizawa H, Nakagawa S, Okada M, Miki A, Myoga A, Sugase T, Sekiguchi C, Miyazawa Y, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.
Nephrology(Carlton).2019 Sep;24(9):904-911.
4. Crucial role of NLRP3 inflammasome in the development of peritoneal dialysis-related peritoneal fibrosis.
Hishida E, Ito H, Komada T, Karasawa T, kimura H, Watanabe S, Kamata R, Aizawa E, Kasahara T, Morishita Y, Akimoto T, Nagata D, Takahashi M.
Sci Rep. 9(1):10363. 2019
5. Effect of Renal Tubule-Specific Knockdown of the Na+/H+ Exchanger NHE3 in Akita Diabetic Mice.
Onishi A, Fu Y, Darshi M, Crespo-Masip M, Huang W, Song P, Patel R, Kim YC, Nespoux J, Freeman B, Soleimani M, Thomson SC, Sharma K, Vallon V.
Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F419-F434. doi: 10.1152/ajprenal.00497.2018. Epub 2019 Jun 5.
6. The role of inflammasomes in kidney disease.
Komada T, Muruve DA.
Nat Rev Nephrol. 2019 Aug;15(8):501-520. doi: 10.1038/s41581-019-0158-z. Review.
7. Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
Nagayama I, Masuda T, Nakagawa S, Murakami T, Ohara K, Matsuoka R, Kobayashi T, Maeshima A, Akimoto T, Saito O, Muto S, Nagata D.
Intern Med. 2019 Jun 1;58(11):1587-1591. doi: 10.2169/internalmedicine.2174-18. Epub 2019 Feb 1.
Song P, Huang W, Onishi A, Patel R, Kim YC, van Ginkel C, Fu Y, Freeman B, Koepsell H, Thomson SC, Liu R, Vallon V.
Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F207-F217. doi: 10.1152/ajprenal.00120.2019. Epub 2019 May 15.
9. Peritoneal Dialysis and Malignancy: An Experience With a Patient Complicated by Gastric Carcinoma.
Akimoto T, Muto S, Kutsuwada T, Kutsuwada K, Nagata D.
Clin Med Insights Case Rep. 2019 Mar 12;12:1179547619835176. doi: 10.1177/1179547619835176. eCollection 2019.
10. SGLT2 inhibition and renal urate excretion: the role of luminal glucose, GLUT9 and URAT1.
Novikov A, Fu Y, Huang W, Freeman B, Patel R, van Ginkel C, Koepsell H, Busslinger M, Onishi A, Nespoux J, Vallon V.
Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F173-F185.
11. Essential points from Evidence-based Clinical Practice Guidelines for Chronic Kidney Disease 2018.
Okada H, Yasuda Y, Kashihara N, Asahi K, Ito T, Kaname S, Kanda E, Kanno Y, Shikata K, Shibagaki Y, Tsuchiya K, Tsuruya K, Nagata D, Narita I, Nangaku M, Hattori M, Hamano T, Fujimoto S, Moriyama T, Yamagata K, Yamamoto R, Wakasugi M, Ashida A, Usui J, Kawamura K, Kitamura K, Konta T, Suzuki Y, Tsuruoka S, Nishio S, Hamano T, Fujii N, Fujii H, Wada T, Yokoyama H, Aoki K, Akiyama D, Araki SI, Arima H, Ishikawa E, Ishikura K, Ishizuka K, Ishimoto T, Ishimoto Y, Iseki K, Itabashi M, Ichioka S, Ichikawa K, Ichikawa D, Inoue S, Imai T, Imamura H, Iwata Y, Iwazu Y, Usui T, Uchida K, Egawa M, Ohara S, Omori N, Okada R, Okuda Y, Ozeki T, Obata Y, Kai H, Kato N, Kanasaki K, Kaneko Y, Kabasawa H, Kawaguchi T, Kawasaki Y, Kawashima K, Kawano H, Kikuchi K, Kihara M, Kimura Y, Kurita N, Koike K, Koizumi M, Kojima C, Goto S, Konomoto T, Kohagura K, Komatsu H, Komaba H, Saito C, Sakai Y, Sakaguchi Y, Satonaka H, Jimi K, Shimizu A, Shimizu S, Shirai S, Shinzawa M, Sugiyama K, Suzuki T, Suzuki H,Suyama K, Segawa H, Takahashi K, Tanaka K, Tanaka T, Tsunoda R, Tsuruta Y, Nakakura H, Nagasawa Y, Nakanishi K, Nagahama M, Nakaya I, Nanami M, Niihata K, Nishi S, Nishiwaki H, Hasegawa S, Hasegawa M, Hanada K, Hayashi H, Harada R, Hishida M, Hirano D, Hirahashi J, Hirama A, Hirayama K, Fukagawa M, Fukuda A, Fujii Y, Fujisaki K, Furuya F, Hoshino J, Hosojima M, Honda K, Masuda T, Matsui K, Matsukuma Y, Matsumura H, Mii A, Miura K, Mitobe M, Miyasato Y, Miyamoto S, Miwa S, Yazawa M, Yata Y,Yamamoto Y, Watanabe K.
Clin Exp Nephrol. 2019 Jan;23(1):1-15.
◆発表論文(和文)
1. 重篤な心停止後症候群に至った後も維持血液透析を継続した2症例(原著論文/症例報告).
大西 央, 小林 高久, 今井 利美, 永山 泉, 川又 睦, 若林 奈津子, 秋元 哲, 齋藤 修, 武藤 重明, 長田 太助
臨床透析 (0910-5808)35巻9号 Page1219-1222 (2019.08)
2. 【JSH2019改訂における重要ポイント(2)CKD合併高血圧の血圧管理】CKD合併高血圧(解説/特集)
増田 貴博, 長田 太助
血圧 (1340-4598)26巻6号 Page345-350 (2019.06)
3. 【慢性腎臓病の管理と今後の展望-新しいガイドラインを考慮して】慢性腎臓病における降圧療法のcontroversy(解説/特集)
増田 貴博, 長田 太助
カレントテラピー (0287-8445)37巻5号 Page464-469 (2019.05)